Osteolysis: Medical and surgical approaches

Clinical Orthopaedics and Related Research

Volumn 427, Issue , 2004, Pages 138-147

  Saleh, Khaled J ^a   Thongtrangan, Issada ^a   Schwarz, Edward M ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; BONE CEMENT; ETANERCEPT; INFLIXIMAB; METHYLXANTHINE DERIVATIVE; MONOCLONAL ANTIBODY; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PENTOXIFYLLINE; PROSTAGLANDIN SYNTHASE INHIBITOR; PROTEIN INHIBITOR; RECEPTOR BLOCKING AGENT; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; UNCLASSIFIED DRUG;

ACETABULUM; ADENO ASSOCIATED VIRUS; BONE; BONE DESTRUCTION; BONE TISSUE; COMPUTER ASSISTED TOMOGRAPHY; FEMUR; GENE THERAPY; HUMAN; IMPLANT; JOINT CAVITY; MEDICAL DECISION MAKING; NONHUMAN; OSTEOLYSIS; PRIORITY JOURNAL; PROSTHESIS; PROSTHESIS LOOSENING; RADIATION EXPOSURE; REVIEW; SOFT TISSUE; SURGICAL TECHNIQUE; THREE DIMENSIONAL IMAGING; TOTAL HIP PROSTHESIS; TREATMENT FAILURE; VIRUS RECOMBINANT;

EID: 5444220270     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/01.blo.0000142288.66246.4d     Document Type: Review

References (66)

1. Amstutz HC, Ma SM, Jinnah RH, Mai L: Revision of aseptic loose total hip arthroplasties. Clin Orthop 170:34-41, 1982.
2. Archibeck MJ, Jacobs JJ, Roebuck KA, Glant TT: The Basic Science of Periprosthetic Osteolysis. In Sim FH (ed). AAOS Instructional Course Lectures. Vol 50. Rosemont, IL, American Academy of Orthopaedic Surgeons 185-195, 2001.
3. Blaha JD: Well-fixed acetabular component retention or replacement. J Arthroplasty 17(Suppl 1):157-161, 2002.
4. Blaine TA, Pollice PF, Rosier RN, et al: Modulation of the production of cytokines in titanium-stimulated human peripheral blood monocytes by pharmacological agents: The role of cAMP-mediated signaling mechanisms. J Bone Joint Surg 79A:1519-1528, 1997.
5. Blam ME, Stein RB, Lichtenstein GR: Integrating anti-tumor necrosis factor therapy in inflammatory bowel disease: Current and future perspectives. Am J Gastroenterol 96:1977-1997, 2001.
6. Brown GC, Lockshin MD, Salvati EA, Bullough PG: Sensitivity to metal as a possible cause of sterile loosening after cobalt-chromium total hip-replacement arthroplasty. J Bone Joint Surg 59A:164-168, 1977.
7. Callaghan JJ, Salvati EA, Pellicci PM, Wilson Jr PD, Ranawat CS: Results of revision for mechanical failure after cemented total hip replacement, 1979 to 1982: A two to five-year follow-up. J Bone Joint Surg 67A:1074-1085, 1985.
8. Carlsson A, Gentz CF: Radiologic versus clinical loosening of the acetabular component in noninfected total hip replacement. Clin Orthop 185:145-150, 1984.
9. Catino MA, Whirlow JE, Sotereanos NG, Crossett LS, Rubash HE: Preoperative Planning for Revision Total Hip Arthroplasty. In Callaghan JJ, Rosenberg AG, Rubash HE (eds). The Adult Hip. Philadelphia, Lippincott-Raven Publishers 1353-1375, 1998.
10. Chatoo M, Parfitt J, Pearse MF: Periprosthetic acetabular fracture associated with extensive osteolysis. J Arthroplasty 13:843-845, 1998.
11. Childs LM, Goater JJ, O'Keefe RJ, Schwarz EM: Efficacy of etanercept for wear debris-induced osteolysis. J Bone Miner Res 16:338-347, 2001.
12. Childs LM, Paschalis EP, Xing L, et al: In vivo RANK signaling blockade using the receptor activator of NF- kappaB:Fc effectively prevents and ameliorates wear debris-induced osteolysis via osteoclast depletion without inhibiting osteogenesis. J Bone Miner Res 17:192-199, 2002.
13. Dean DD, Schwartz Z, Blanchard CR, et al: Ultrahigh molecular weight polyethylene particles have direct effects on proliferation, differentiation, and local factor production of MG63 osteoblast-like cells. J Orthop Res 17:9-17, 1999.
14. Devane PA, Horne JG, Coldham G, Krause B: Three dimensional polyethylene wear of a press fit titanium prosthesis: Factor influencing generation of polyethylene debris. J Arthroplasty 12:256-266, 1997.
15. Dezube BJ, Pardee AB, Chapman B, et al: Pentoxifylline decreases tumor necrosis factor expression and serum triglycerides in people with AIDS. NIAID AIDS Clinical Trials Group. J Acquir Immune Defic Syndr 6:787-794, 1993.
16. Dunbar MJ, Blackley HRL, Bourne RB: Osteolysis of the Femur: Principles of Management. In Sim FH (ed). AAOS Instructional Course Lectures. Vol 50. Rosemont, IL, American Academy of Orthopaedic Surgeons 197-209, 2001.
17. Evans EM: Metal sensitivity as a cause of bone necrosis and loosening of the prosthesis in total joint replacement. J Bone Joint Surg 56B:626-642, 1974.
18. Goetz DD, Smith EJ, Harris WH: The prevalence of femoral osteolysis associated with components inserted with or without cement in total hip replacements: A retrospective matched-pair series. J Bone Joint Surg 76A:1121-1129, 1994.
19. Goldring SR, Schiller AL, Roelke M, et al: The synovial-like membrane at the bone-cement interface in loose total hip replacements and its proposed role in bone lysis. J Bone Joint Surg 65A:575-584, 1983.
20. Goodman SB, Chin RC, Chiou SS, Lee JS: Suppression of prostaglandin E2 synthesis in the membrane surrounding particulate polymethylmethacrylate in the rabbit tibia. Clin Orthop 244:300-304, 1991.
21. Goodman SB, Lee JS, Chin RC, Chiou SS: Modulation of the membrane surrounding particulate cement and polyethylene in the rabbit tibia. Biomaterials 12:194-196, 1991.
22. Gross AE, Blackley H, Wong P, Saleh KJ, Woodgate I: The use of allografts in orthopaedic surgery: Part II. The role of allografts in revision arthroplasty of the hip. J Bone Joint Surg 84A:655-667, 2002.
23. Gross AE, Blackley H, Wong P, Saleh KJ, Woodgate I: The Role of Allografts in Revision Arthroplasty of The Hip. In Beaty JH (ed). AAOS Instructional Course Lectures. Vol 51. Rosemont, IL, American Academy of Orthopaedic Surgeons 103-113, 2002.
24. Herberts P, Malchau H: How outcome studies have changed total hip arthroplasty practices in Sweden. Clin Orthop 344:44-60, 1997.
25. Hodgkinson JP, Shelley P, Wroblewski BM: The correlation between the rontgenographic appearance and operative findings at the bone cement junction of the socket in Charnley low friction arthroplasties. Clin Orthop 228:105-109, 1988.
26. Hofbauer LC, Khosla S, Dunstan CR, et al: The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res 15:2-12, 2000.
27. Howell ED, Bourne RB: Osteolysis: Etiology, Prosthetic factors, and Pathogenesis. In Price CT (ed). AAOS Instructional Course Lectures. Vol 49. Rosemont, IL, American Academy of Orthopaedic Surgeons 71-82, 2000.
28. Hozack WJ, Mesa JJ, Carey C, Rothman RH: Relationship between polyethylene wear, pelvic osteolysis, and clinical symptomatology in patients with cementless acetabular components: A framework for decision making. J Arthroplasty 11:769-772, 1996.
29. Imai S, Konttinen YT, Jumppanen M, et al: High levels of expression of collagenase-3 (MMP-13) in pathological conditions associated with a foreign-body reaction. J Bone Joint Surg 80B:701-710, 1998.
30. Jacobs JJ, Kull LR, Frey GA, et al: Early failure of acetabular components inserted without cement after previous pelvic irradiation. J Bone Joint Surg 77A:1829-1835, 1995.
31. Jerosch J, Steinbeck J, Fuchs S, Kirchoff C: Radiologic evaluation of acetabular defects on acetabular loosening of hip arthroplasty. Unfallchirug 99:727-733, 1996.
32. Jones LC, Hungerford DS: Cement disease. Clin Orthop 225:192-206, 1987.
33. Kennedy JG, Rogers WB, Soffe KE, Griffen DG, Sheehan LJ: Effect of acetabular component orientation on recurrent dislocation, polyethylene wear and component migration. J Arthroplasty 13:530-534, 1998.
34. Kobayashi S, Saito N, Horiuchi H, Iorio R, Takaoka K: Poor bone quality or hip structure as risk factors affecting survival of total-hip arthroplasty. Lancet 355:1499-1504, 2000.
35. Lavernia CJ, Drakeford MK, Tsao AK, et al: Revision and primary hip and knee arthroplasty: A cost analysis. Clin Orthop 311:136-141, 1995.
36. Lipsky PE, van der Heijde DM, St Clair EW, et al: Infliximab and methotrexate in the treatment of rheumatoid arthritis: Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. N Engl J Med 343:1594-1602, 2000.
37. Looney RJ, Boyd A, Totterman S, et al: Volumetric computerized tomography as a measurement of periprosthetic acetabular osteolysis and its correlation with wear. Arthritis Res 4:59-63, 2002.
38. Maloney WJ, Galante JO, Anderson M, et al: Fixation, polyethylene wear, and pelvic osteolysis in primary total hip replacement. Clin Orthop 369:157-164, 1999.
39. Maloney WJ, Paprosky WG, Engh CA, Rubash HF: Surgical treatment of osteolysis. Clin Orthop 393:78-84, 2001.
40. Martell JM, Pierson III RH, Jacobs JJ, et al: Primary total hip reconstruction with a titanium fiber-coated prosthesis inserted without cement. J Bone Joint Surg 75A:554-571, 1993.
41. McGann WA, Welch RB, Picetti III GD: Acetabular preparation in cementless total hip arthroplasty. Clin Orthop 235:35-46, 1988.
42. Millett PJ, Allen MJ, Bostrom MP: Effects of alendronate on particle-induced osteolysis in a rat model. J Bone Joint Surg 84A:236-249, 2002.
43. Pollice PF, Rosier RN, Looney RJ, et al: Oral pentoxifylline inhibits release of tumor necrosis factor-alpha from human peripheral blood monocytes: A potential treatment for aseptic loosening of total joint components. J Bone Joint Surg 83A:1057-1061, 2001.
44. Puri L, Wixson RL, Stern SH, et al: Use of helical computed tomography for the assessment of acetabular osteolysis after total hip arthroplasty. J Bone Joint Surg 84A:609-614, 2002.
45. Rooker GD, Wilkinson JD: Metal sensitivity in patients undergoing hip replacement: A prospective study. J Bone Joint Surg 62B:502-505, 1980.
46. Rubash HE, Sinha RK, Engh CA, et al: A New Classification System for the Management of Acetabular Osteolysis after Total Hip Arthroplasty. In Zuckerman JD (ed). American Academy of Orthopaedic Surgeons Instructional Course Lectures. Vol 48. Rosemont, IL, American Academy of Orthopaedic Surgeons 37-42, 1999.
47. Saleh KJ, Wood K, Gafni A, Gross A: Immediate surgery versus waiting list policy in revision total hip arthroplasty: An economic evaluation. J Arthroplasty 12:1-10, 1997.
48. Sanchez-Sotelo J, McGrory BJ, Berry DJ: Acute periprosthetic fracture of the acetabulum associated with osteolytic pelvic lesions: A report of 3 cases. J Arthroplasty 15:126-130, 2000.
49. Schmalzried TP: Mechanical Failure-Loosening and Wear. In Pellicci PM, Tria Jr AJ, Garvin KL (eds). Orthopaedic Knowledge Update 2: Hip and Knee Reconstruction. Rosemont, IL, American Academy of Orthopaedic Surgeons 167-174, 2000.
50. Schmalzried TP, Callaghan JJ: Wear in total hip and knee replacements. J Bone Joint Surg 81A:115-136, 1999.
51. Schmalzried TP, Fowble VA, Amstutz HC: The fate of pelvic osteolysis after reoperation: No recurrence with lesional treatment. Clin Orthop 350:128-137, 1998.
52. Schmalzried TP, Guttmann D, Grecula M, Amstutz HC: The relationship between the design, position, and articular wear of acetabular components inserted without cement and the development of pelvic osteolysis. J Bone Joint Surg 76A:677-688, 1994.
53. Schmalzried TP, Szuszczewicz ES, Northfield MR, et al: Quantitative assessment of walking activity after total hip or knee replacement. J Bone Joint Surg 80A:54-59, 1998.
54. Schwarz EM, O'Keefe RJ: Breakthough in bone: The molecular mechanism of osteoclast/osteoblast coupling revealed. Curr Opin Orthop 11:329-335, 2000.
55. Shanbhag AS, Hasselman CT, Rubash HE: The John Charnley Award: Inhibition of wear debris mediated osteolysis in a canine total hip arthroplasty model. Clin Orthop 344:33-43, 1997.
56. Shih CH, Lee PC, Chen JH, et al: Measurement of polyethylene wear in cementless total hip arthroplasty. J Bone Joint Surg 79B:361-365, 1997.
57. Singha RK, Maloney WJ, Paprosky WG, Rubash HF: Surgical Treatment of Osteolysis. In Callaghan JJ, Rosenberg AG, Rubash HE (eds). The Adult Hip. Philadelphia, Lippincott-Raven Publishers 1551-1552, 1998.
58. Sochart DH: Relationship of acetabular wear to osteolysis and loosening in total hip arthroplasty. Clin Orthop 363:135-150, 1999.
59. Stulberg SD, Wixson RL, Adams AD, Hendrix RW, Bernfield JB: Monitoring pelvic osteolysis following total hip replacement surgery: An algorithm for surveillance. J Bone Joint Surg 84A(Suppl 2):116-122, 2002.
60. Sutherland CJ: Radiographic evaluation of acetabular bone stock in failed total hip arthroplasty. J Arthroplasty 3:73-79, 1988.
61. Tanzer M, Maloney WJ, Jasty M, Harris WH: The progression of femoral cortical osteolysis in association with total hip arthroplasty without cement. J Bone Joint Surg 74A:404-410, 1992.
62. Ulrich-Vinther M, Carmody EE, Goater JJ, et al: Recombinant adeno-associated virus-mediated osteoprotegerin gene therapy inhibits wear debris-induced osteolysis. J Bone Joint Surg 84A:1405-1412, 2002.
63. Wenz JF, Hauser DL, Scott WW, et al: Observer variation in the detection of acetabular bone deficiencies. Skeletal Radiol 26:272-278, 1997.
64. Woodgate I, Saleh KJ, Jaroszynski G, et al: A minor column structural acetabular allografts in revision hip arthroplasty. Clin Orthop 371:75-85, 2000.
65. Zhang X, Morham SG, Langenbach R, et al: Evidence for a direct role of COX-2 in implant wear debris induced osteolysis. J Bone Miner Res 16:660-670, 2001.
66. Zhang X, Schwarz EM, Young DA, et al: Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. J Clin Invest 109:1405-1415, 2002.